|Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II–induced cardiac hypertrophy|
JA Byrne,*, DJ Grieve, JK Bendall, JM Li, C Gove, JD Lambeth, AC Cave, ...
Circulation research 93 (9), 802-805, 2003
|Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19|
A Hua, K O’Gallagher, D Sado, J Byrne
European heart journal 41 (22), 2130-2130, 2020
|Oxidative stress and heart failure.|
JA Byrne, DJ Grieve, AC Cave, AM Shah
Archives des Maladies du Coeur et des Vaisseaux 96 (3), 214-221, 2003
|Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload|
DJ Grieve, JA Byrne, A Siva, J Layland, S Johar, AC Cave, AM Shah
Journal of the American College of Cardiology 47 (4), 817-826, 2006
|Role of oxidative stress in cardiac remodelling after myocardial infarction|
DJ Grieve, JA Byrne, AC Cave, AM Shah
Heart, Lung and Circulation 13 (2), 132-138, 2004
|Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo|
M Seddon, N Melikian, R Dworakowski, H Shabeeh, B Jiang, J Byrne, ...
Circulation 119 (20), 2656-2662, 2009
|Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention|
T Nageh, RA Sherwood, BM Harris, JA Byrne, MR Thomas
International journal of cardiology 92 (2-3), 285-293, 2003
|2-year outcomes of high bleeding risk patients after polymer-free drug-coated stents|
P Garot, MC Morice, D Tresukosol, SJ Pocock, IT Meredith, A Abizaid, ...
Journal of the American College of Cardiology 69 (2), 162-171, 2017
|Percutaneous closure of postinfarction ventricular septal defect: in-hospital outcomes and long-term follow-up of UK experience|
PA Calvert, J Cockburn, D Wynne, P Ludman, BS Rana, D Northridge, ...
Circulation 129 (23), 2395-2402, 2014
|Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic|
A Banerjee, S Chen, L Pasea, AG Lai, M Katsoulis, S Denaxas, V Nafilyan, ...
European journal of preventive cardiology 28 (14), 1599-1609, 2021
|Chronic kidney injury in patients after cardiac catheterisation or percutaneous coronary intervention: a comparison of radial and femoral approaches (from the British Columbia …|
T Vuurmans, J Byrne, E Fretz, C Janssen, JD Hilton, WP Klinke, ...
Heart 96 (19), 1538-1542, 2010
|ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION) a randomized clinical trial|
T Patterson, T Clayton, M Dodd, Z Khawaja, MC Morice, K Wilson, ...
Cardiovascular Interventions 14 (18), 1965-1974, 2021
|A practical risk score for early prediction of neurological outcome after out-of-hospital cardiac arrest: MIRACLE2|
N Pareek, P Kordis, N Beckley-Hoelscher, D Pimenta, ST Kocjancic, ...
European heart journal 41 (47), 4508-4517, 2020
|Aortic dissection: medical, interventional and surgical management|
M Silaschi, J Byrne, O Wendler
Heart 103 (1), 78-87, 2017
|Transcatheter aortic valve replacement using the repositionable LOTUS valve: United Kingdom experience|
R Rampat, MZ Khawaja, J Byrne, P MacCarthy, DJ Blackman, ...
Cardiovascular Interventions 9 (4), 367-372, 2016
|Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry)|
J Byrne, MS Spence, E Fretz, R Mildenberger, A Chase, B Berry, D Pi, ...
The American journal of cardiology 103 (4), 507-511, 2009
|Inception of the ‘endocarditis team’is associated with improved survival in patients with infective endocarditis who are managed medically: findings from a before-and-after study|
A Kaura, J Byrne, A Fife, R Deshpande, M Baghai, M Gunning, D Whitaker, ...
Open Heart 4 (2), e000699, 2017
|A calcific, undilatable stenosis: lithoplasty, a new tool in the box?|
K De Silva, J Roy, I Webb, R Dworakowski, N Melikian, J Byrne, ...
JACC: Cardiovascular Interventions 10 (3), 304-306, 2017
|Cardiac injury after percutaneous catheter ablation for atrial fibrillation|
LM Haegeli, E Kotschet, J Byrne, DC Adam, EE Lockwood, RA Leather, ...
Europace 10 (3), 273-275, 2008
|Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention|
I Olier, A Sirker, DJR Hildick-Smith, T Kinnaird, P Ludman, MA De Belder, ...
Heart 104 (20), 1683-1690, 2018